India  /  Published 27.07.20

Covid: Itolizumab protocol cloud

The National Task Force on the new coronavirus disease has decided that there is not enough evidence yet to include the drug itolizumab in Covid-19 treatment protocols even though India’s drug r...
By G.S. Mudur in New Delhi

India  /  Published 14.07.20

Covid: trial size tempers hope

Bangalore-based Biocon on Monday released what it said were “compelling” clinical trial results indicating that itolizumab, a drug the firm manufactures, can reduce the need for ventilator...
By G.S. Mudur in New Delhi

Business  /  Published 05.06.20

Award for Shaw

Biocon executive chairperson Kiran Mazumdar-Shaw has been named EY World Entrepreneur of the Year 2020 at a virtual award ceremony, the company said in a statement. She was selected from among 46 Ent...
By TT Bureau in Calcutta

India  /  Published 19.09.19

Nirmala to Kiran: Am working

Finance minister Nirmala Sitharaman on Thursday defended her handling of her job in response to a critical tweet from industrialist Kiran Mazumdar-Shaw, asserting she was working on measures to revive...
By PTI in New Delhi

India  /  Published 03.08.19

Yes, I was told not to say such things: Kiran Mazumdar-Shaw

Biocon chief Kiran Mazumdar Shaw has confirmed that “a government official” called her recently and told her not to speak about issues such as income tax harassment that has drawn attention after ...
By K.M. Rakesh in Bangalore

Business  /  Published 19.02.20

Biocon chief Kiran Mazumdar-Shaw bags EY award

Kiran Mazumdar-Shaw, chairperson and managing director of Biocon, has been named the EY Entrepreneur of the Year 2019 and will now represent India at the EY World Entrepreneur of the Year Award in Mon...
By TT Bureau in New Delhi

India  /  Published 30.08.19

Shock slowdown

The Indian economy grew at its slowest pace in more than six years at 5 per cent in the first quarter of 2019-20, deepening worries about subdued factory output and resultant job losses.It also fanned...
By R. Suryamurthy in New Delhi

Business  /  Published 27.01.20

US lens on Biocon unit

Bangalore-based Biocon on Monday said the US Food and Drug Administration (US FDA) conducted a pre-approval inspection and good manufacturing practice (GMP) examination of its API manufacturing facili...
By TT Bureau in Mumbai


Download our latest App

to get update on the go...


Copyright © 2020 The Telegraph. All rights reserved.